NanOX 4 Kidney – a new generation kidney perfusion fluid based on a synthetiz oxygen carrier

NanOX 4 Kidney – a new generation kidney perfusion fluid based on a synthetiz oxygen carrier

NanOX 4 Kidney – a new generation kidney perfusion fluid based on a synthetiz oxygen carrier

NanoSanguis, a subsidiary of NanoGroup, is implementing the NanOX 4 Kidney project – a new generation kidney perfusion fluid based on a synt…

Dextran Conjugates for Targeted Anticancer Therapy

Dextran Conjugates for Targeted Anticancer Therapy

2024/ABM/05/KPO/KPOD.07.07-IW.07-0249/24NanoSanguis Sp. z o.o. is carrying out the project titled “Dextran Conjugates for Targeted Anticancer Therapy…

Preclinical and Clinical Studies of Innovative Nanoformulations of Anticancer Drugs

Preclinical and Clinical Studies of Innovative Nanoformulations of Anticancer Drugs

POIR.01.01.01-00-0021/16-00 POIR.01.01.01-00-0021/16-00 Between 2016 and 2022, NanoVelos Ltd. carried out a project co-financed by the European Funds …

Wsparcie dla ochrony patentowej zgłoszenia PCT dla technologii i zastosowania nośników polisacharydowych dedykowanych do leczenia onkologicznego

Wsparcie dla ochrony patentowej zgłoszenia PCT dla technologii i zastosowania nośników polisacharydowych dedykowanych do leczenia onkologicznego

Wsparcie dla ochrony patentowej zgłoszenia PCT dla technologii i zastosowania nośników polisacharydowych dedykowanych do leczenia onkologicznego PP3/W…

Development of New Cancer Therapies Based on Selective Anticancer Immunomodulators

Development of New Cancer Therapies Based on Selective Anticancer Immunomodulators

STRATEGMED2/265503/3/NCBR/2015 The goal of this project is to develop an innovative therapeutic approach for cancer treatment – small molecule immunomodula…

A nanoscale polysaccharide-based delivery system for targeted oncological therapy with 5-fluorouracil.

A nanoscale polysaccharide-based delivery system for targeted oncological therapy with 5-fluorouracil.

PBS3/B7/24/2015 The Nano5-FU project is being carried out by NanoVelos S.A. as the leader of a consortium in collaboration with two academic…

pp-thumbnail